Vimarsana
Biggest News Aggregation in the World

Page 44 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Android. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Android Today - Breaking & Trending Today

Study characterizes food protein-induced enterocolitis syndrome in adults - Vimarsana News

Study characterizes food protein-induced enterocolitis syndrome in adults

Adults and children have different experiences with food protein-induced enterocolitis syndrome, although more research is necessary, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Specifically, unlike what has been document in the pediatric population, the adult cohort less frequently experienced vomiting, severe acute episodes and development of

Source: healio.com
AI algorithm shows promise for early identification of geographic atrophy biomarkers - Vimarsana News

AI algorithm shows promise for early identification of geographic atrophy biomarkers

FORT LAUDERDALE, Fla. — A machine-learning algorithm showed the ability to identify spectral-domain OCT predictors of geographic atrophy in eyes with intermediate age-related macular degeneration.

Source: healio.com
Intestinal absorbent improves short-term stool consistency, abdominal pain in IBS-D - Vimarsana News

Intestinal absorbent improves short-term stool consistency, abdominal pain in IBS-D

SAN DIEGO — Enterosgel, a CE-certified intestinal absorbent, reduced short-term symptoms of stool consistency and abdominal pain among patients with irritable bowel syndrome with diarrhea, according to research. “The RELIEVE-IBS-D study was set up to investigate the efficacy and safety of Enterosgel for the treatment of irritable bowel syndrome with diarrhea. Enterosgel is a

Source: healio.com
Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution - Vimarsana News

Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution

SAN DIEGO — Patients who underwent laparoscopic anti-reflux surgery for gastroesophageal reflux disease experienced long-term improvement in symptoms commonly misperceived to persist, according to study results. “Our take home-message is to make patients as well as our colleagues — not only the surgeons but also the primary care physicians and gastroenterologists — who

Source: healio.com
Ustekinumab biosimilar candidate achieves 'therapeutic equivalence' - Vimarsana News

Ustekinumab biosimilar candidate achieves 'therapeutic equivalence'

AVT04, a biosimilar candidate to ustekinumab developed by Alvotech, met the primary endpoint in a confirmatory clinical study of patients with chronic plaque-type psoriasis, according to a company press.

Source: healio.com